Exertional dyspnea in chronic obstructive pulmonary disease: Mechanisms and treatment approaches

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 144-149

  Ora, Josuel ^a   Jensen, Dennis ^a   O'Donnell, Denis E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Dyspnea; Exercise; Heliox; Inhaled furosemide

Indexed keywords

ENDORPHIN; FUROSEMIDE; HELIUM; OPIATE DERIVATIVE; OXYGEN;

ANXIETY; BREATHING EXERCISE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; FEAR; HUMAN; LIMBIC CORTEX; NEUROIMAGING; OXYGEN THERAPY; REVIEW;

ANALGESICS, OPIOID; DYSPNEA; FEEDBACK, PHYSIOLOGICAL; FUROSEMIDE; HUMANS; PHYSICAL EXERTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 76449091139     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328334a728     Document Type: Review

References (33)

1. O'Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009; 34:866-874.
2. Nishimura K, Izumi T, TsukinoM, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
3. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4:145-168. (Pubitemid 46743309)
4. Mahler DA, Baird JC. Are you fluent in the language of dyspnea? Chest 2008; 134:476-477.
5. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996; 154:1357-1363.
6. Harver A, Mahler DA, Schwartzstein RM, Baird JC. Descriptors of breathlessness in healthy individuals: distinct and separable constructs. Chest 2000; 118:679-690.
7. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109-115.
8. Ofir D, Laveneziana P, Webb KA, et al. Sex differences in the perceived intensity of breathlessness during exercise with advancing age. J Appl Physiol 2008; 104:1583-1593.
9. Jensen D, Ofir D, O'Donnell DE. Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans. Respir Physiol Neurobiol 2009; 167:87-100.
10. Williams M, Cafarella P, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest 2008; 134:489-496.
11. Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/ effort. Am J Respir Crit Care Med 2008; 177:1384-1390.
12. von Leupoldt A, Sommer T, Kegat S, et al. Dyspnea and pain share emotionrelated brain network. Neuroimage 2009; 48:200-206.
13. Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2009; 167:72-86.
14. Santiago TV, Edelman NH. Opioids and breathing. J Appl Physiol 1985; 59:1675-1685.
15. Mahler DA, Murray JA, Waterman LA, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009; 33:771-777.
16. O'Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009; 167:116-132.
17. Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:622-629.
18. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 2009; 106:1902-1908.
19. O'Donnell DE, Laveneziana P, Ora J, et al. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009; 64:216-223.
20. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180:506-512.
21. Ora J, Laveneziana P, Ofir D, et al. Combined effects of obesity and COPD on dyspnea and exercise tolerance. Am J Respir Crit Care Med 2009 [Epub ahead of print].
22. Nishino T, Ide T, Sudo T, Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000; 161:1963-1967.
23. Ong KC, Kor AC, Chong WF, et al. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169:1028-1033.
24. Jensen D, Amjadi K, Harris-McAllister V, et al. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 2008; 63:606-613.
25. Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009; 360:1329-1335.
26. Eves ND, Petersen SR, Haykowsky MJ, et al. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174:763-771.
27. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:892-898.
28. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97:1637-1642.
29. Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med 2006; 173:865-870.
30. Marciniuk DD, Butcher SJ, Reid JK, et al. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest 2007; 131:1659-1665.
31. Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990; 69:179-188.
32. Eves ND, Sandmeyer LC, Wong EY, et al. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest 2009; 135:609-618.
33. Collins EG, Langbein WE, Fehr L, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2008; 177:844-852.